Cargando…
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination is crucial to develop strategies for longer term immunity, especially against emerging viral variants. We profiled serial paired mucosal and plasma antibodies from COVID-19 vaccinated only vaccinees (vaccinated, un...
Autores principales: | Selva, Kevin J., Ramanathan, Pradhipa, Haycroft, Ebene R., Reynaldi, Arnold, Cromer, Deborah, Tan, Chee Wah, Wang, Lin-Fa, Wines, Bruce D., Hogarth, P. Mark, Downie, Laura E., Davis, Samantha K., Purcell, Ruth A., Kent, Helen E., Juno, Jennifer A., Wheatley, Adam K., Davenport, Miles P., Kent, Stephen J., Chung, Amy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561726/ https://www.ncbi.nlm.nih.gov/pubmed/37737263 http://dx.doi.org/10.1172/jci.insight.172470 |
Ejemplares similares
-
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
por: Lee, Wen Shi, et al.
Publicado: (2021) -
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
por: Haycroft, Ebene R., et al.
Publicado: (2023) -
Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021) -
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021) -
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022)